Prof Derek Chew

Phone: +61 8 84042001
Email:
Location: School of Medicine (6R:367)
Postal address: GPO Box 2100, Adelaide 5001, South Australia

Biography

Derek Chew is a clinical and interventional cardiologist as well as a clinical trialist and outcomes researcher in cardiovascular medicine. He has completed a Masters of Public Health at the Harvard School of Public Health in quantitative methods. He is a Senior Principal Research Fellow in Cardiovascular Outcomes Research, and is the Regional Head of Cardiology for the Adelaide Health Service (Southern Region). Derek is the Head of the Flinders Clinical Trial Centre, and Chair of the Statewide Cardiology Clinical Network. His clinical and research career is centred on the translation of current and future therapies and technologies in cardiology to improved patient outcomes in a clinically effective manner.

Qualifications

MBBS, MPH, FRACP

Key responsibilities

Edwards Heart Foundation Senior Research Fellow
Professor of Cardiology, Flinders University
Regional Director of Cardiology, Department of Cardiovascular Medicine, Adelaide Health Service (Southern Region)
Head, Flinders Centre for Clinical Change & Health Care Research

Research and supervision

Research interests

With the expanding array of therapeutic options available for the clinical care of patients presenting with cardiovascular disease, optimal and cost-effective clinical outcomes will require, not only innovations in pharmacology and device development, but also their careful and evidence-based application to the clinical community. These choices and recommendations can be informed by careful, well-conducted clinical research within the context of current day clinical practice. Derek seeks to design and undertake clinical studies to inform these choices, improve the delivery of proven therapies, identify clinical groups within the entire Australian community that are not currently well served by technologies/therapies and ultimately optimise patient outcomes.

Publications

Book chapters
  • Chew, D. (2011). Anticoagulation in PCI. In EJ Topol, PS Teirstein, ed. Textbook of Interventional Cardiology. USA: Saunders, pp. 113-125. [Link]
  • Chew, D. and Huynh, L. (2011). Applying evidence based medicine, guidelines and clinical pathways in the Coronary Care Unit: Bridging the Last Mile. In Peter L Thompson, ed. Coronary Care Manual, 2nd Edition. Chatswood, New South Wales: Elsevier Australia, pp. 12-18. [Link]
  • Chew, D. and Huynh, L. (2011). Applying evidence based medicine, guidelines and clinical pathways in the Coronary Care Unit: Bridging the Last Mile. In Peter L Thompson, ed. Coronary Care Manual, 2nd Edition. Chatswood, New South Wales: Elsevier Australia, pp. 12-18. [Link]
  • Chew, D. (2008). Anticoagulation in PCI. In Eric J Topol, ed. Textbook of Interventional Cardiology 5th Edition. USA: Saunders Elsevier, pp. 165-182. [Link]
  • Chew, D., Lehman, S. and White, H. (2007). Direct Thrombin inhibition in Percutaneous Coronary Intervention. In Nicholas N Kipshidze, ed. Textbook of Interventional Cardiovascular Pharmacology. UK: CRC Press, pp. 85-92. [Link]
  • Chew, D. and White, H. (2004). Pathophysiology, Classification and Clinical Features of ACS. In Deepak L Bhatt & Marcus D Flather, ed. Handbook of Acute Coronary Syndromes. UK: Remedica Publishing, pp. 1-22. [Link]
  • Chew, D. (2002). Anti-thrombin Therapy in Percutaneous Coronary Intervention. In NA, ed. The Year in Interventional Cardiology. UK: CRC Press, pp. 30-38. [Link]
  • Chew, D. and Lincoff, A. (2002). Adjunctive Pharmacotherapy and Coronary Intervention. In Ever D Grech, ed. Practical INterventional Cardiology. 2 ed. UK: Martin Dunitz, pp. 0-0. [Link]
  • Chew, D., Szczech, L., Coladonato, J. and Reddan, D. (2002). The Heart and the Renal System. In Eric J Topol, ed. Textbook of Cardiovascular Medicine. NA: Lippincott Williams and Wilkins, pp. 797-814. [Link]
  • Chew, D. and Horrigan, M. (2001). Catheter-based Reperfusion for Acute Myocardial Infarction. In John Boland, David Muller, ed. Cardiology and Cardiac Catheterisation: the essential guide. Netherlands: Harwood Academic Publishers, pp. 231-244. [Link]

Show all publications

Book chapters
  • Chew, D. (2011). Anticoagulation in PCI. In EJ Topol, PS Teirstein, ed. Textbook of Interventional Cardiology. USA: Saunders, pp. 113-125. [Link]
  • Chew, D. and Huynh, L. (2011). Applying evidence based medicine, guidelines and clinical pathways in the Coronary Care Unit: Bridging the Last Mile. In Peter L Thompson, ed. Coronary Care Manual, 2nd Edition. Chatswood, New South Wales: Elsevier Australia, pp. 12-18. [Link]
  • Chew, D. and Huynh, L. (2011). Applying evidence based medicine, guidelines and clinical pathways in the Coronary Care Unit: Bridging the Last Mile. In Peter L Thompson, ed. Coronary Care Manual, 2nd Edition. Chatswood, New South Wales: Elsevier Australia, pp. 12-18. [Link]
  • Chew, D. (2008). Anticoagulation in PCI. In Eric J Topol, ed. Textbook of Interventional Cardiology 5th Edition. USA: Saunders Elsevier, pp. 165-182. [Link]
  • Chew, D., Lehman, S. and White, H. (2007). Direct Thrombin inhibition in Percutaneous Coronary Intervention. In Nicholas N Kipshidze, ed. Textbook of Interventional Cardiovascular Pharmacology. UK: CRC Press, pp. 85-92. [Link]
  • Chew, D. (2006). Platelets, Anti-platelet therapy and Inflammation. In Ridker & Rafai, ed. CRP: Atherothrombosis and Cardiovascular risk. NA: NA.
  • Chew, D. and White, H. (2004). Pathophysiology, Classification and Clinical Features of ACS. In Deepak L Bhatt & Marcus D Flather, ed. Handbook of Acute Coronary Syndromes. UK: Remedica Publishing, pp. 1-22. [Link]
  • Chew, D. (2002). Anti-thrombin Therapy in Percutaneous Coronary Intervention. In NA, ed. The Year in Interventional Cardiology. UK: CRC Press, pp. 30-38. [Link]
  • Chew, D. and Lincoff, A. (2002). Adjunctive Pharmacotherapy and Coronary Intervention. In Ever D Grech, ed. Practical INterventional Cardiology. 2 ed. UK: Martin Dunitz, pp. 0-0. [Link]
  • Chew, D., Szczech, L., Coladonato, J. and Reddan, D. (2002). The Heart and the Renal System. In Eric J Topol, ed. Textbook of Cardiovascular Medicine. NA: Lippincott Williams and Wilkins, pp. 797-814. [Link]
  • Chew, D. and Horrigan, M. (2001). Catheter-based Reperfusion for Acute Myocardial Infarction. In John Boland, David Muller, ed. Cardiology and Cardiac Catheterisation: the essential guide. Netherlands: Harwood Academic Publishers, pp. 231-244. [Link]
  • Chew, D. and Topol, E. (2001). Stents: Indications and Limitations. In Eric J Topol, ed. Textbook of Interventional Cardiology. Unknown: Saunders, pp. 0-0. [Link]
Refereed journal articles
  • Walters, D., Sinhal, A., Baron, D., Pasupati, S., Thambar, S., Yong, G., et al. (2014). Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: The SOURCE ANZ registry: Outcomes at 30days and one year. International Journal of Cardiology, 170(3) pp. 406-412. [Link]
  • Chew, D., Juergens, C., French, J., Parsonage, W., Horsfall, M., Brieger, D., et al. (2014). An examination of clinical intuition in risk assessment among acute coronary syndromes patients: Observations from a prospective multi-center international observational registry. International Journal of Cardiology, 171(2) pp. 209-216. [Link]
  • Chew, D., Junbo, G., Parsonage, W., Kerkar, P., Sulimov, V., Horsfall, M., et al. (2014). Perceived Risk of Ischemic and Bleeding Events in Acute Coronary Syndromes. Circulation: Cardiovascular Quality and Outcomes, 6 pp. 299-308. [Link]
  • Knuiman, M., Briffa, T., Divitini, M., Chew, D., Eikelboom, J., McQuillan, B., et al. (2014). A cohort study examination of established and emerging risk factors for atrialfibrillation: the Busselton Health Study. EUROPEAN JOURNAL OF EPIDEMIOLOGY, [Link]
  • Davis, I. and Chew, D. (2013). Clinical effectiveness research: a critical need for health sector research governance capacity. MJA Medical Journal of Australia, 198(4) pp. 191-192. [Link]
  • Ellis, C., Gamble, G., Devlin, G., Elliott, J., Hamer, A., Williams, M., et al. (2013). The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional care. New Zealand Medical Journal, 126(1387) pp. 36-68. [Link]
  • Kinnaird, T., Medic, G., Casella, G., Schiele, F., Kaul, U., Radke, P., et al. (2013). Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a network meta-analysis. Journal of Blood Medicine, 4 pp. 129-140. [Link]
  • Malkin, C., Judd, J., Chew, D. and Sinhal, A.R. (2013). Balloon aortic valvuloplasty to bridge and triage patients in the era of trans-catheter aortic valve implantation. Catheterization and Cardiovascular Interventions, 81(2) pp. 358-363. [10.1002/ccd.24325]
  • R, P., Joseph, M., Chew, D., Aylward, P. and De Pasquale, C. (2013). Coronary Artery Wall Thickness of the Left Anterior Descending Artery Using High Resolution Transthoracic Echocardiography - Normal Range of Values. Echocardiography-A Journal of Cardiovascular Ultrasound and Allied Techniques, 30(7) pp. 759-764. [Link]
  • Roe, Y., Zeitz, C., Mittinty, M., McDermott, R. and Chew, D. (2013). Impact of age, gender and indigenous status on access to diagnostic coronary angiography for patients presenting with non-ST segment elevation acute coronary syndromes in Australia. Internal Medicine Journal, 43(3) pp. 317-322. [Link]
  • Wong, D., Leung, M., Das, R., Liew, G., Teo, K., Chew, D., et al. (2013). Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size. International Journal of Cardiology, 165(1) pp. 61-66. [10.1016/j.ijcard.2011.07.078]
  • Wong, D., Leung, M., Das, R., Liew, G., Teo, K., Chew, D., et al. (2013). Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size. International Journal of Cardiology, 165(1) pp. 61-66. [Link]
  • Cullen, L., Greenslade, J., Hammett, C., Brown, A., Chew, D., Bilesky, J., et al. (2013). Comparison of three risk stratification rules for predicting patients with acute coronary syndrome presenting to an Australian emergency department. Heart, Lung and Circulation, 22(10) pp. 844-851. [Link]
  • Aliprandi-Costa, B., Ranasinghe, I., Turnbull, F., Brown, A., Kritharides, L., Patel, A., et al. (2013). The Design and Rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE) Heart, Lung and Circulation, 22(7) pp. 533-541. [10.1016/j.hlc.2012.12.013]
  • Worthley, S., Tsioufis, C., Worthley, M., Sinhal, A., Chew, D., Meredith, I., et al. (2013). Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. European Heart Journal, 34(28) pp. 2132-2140. [Link]
  • Chew, D., French, J., Briffa, T., Hammett, C., Ellis, C., Ranasinghe, I., et al. (2013). Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study. MJA Medical Journal of Australia, 199(3) pp. 185-191. [Link]
  • Chew, D. and Scott, I. (2013). The changing face of cardiovascular care in Australia. MJA Medical Journal of Australia, 198(11) pp. 604-605. [Link]
  • Farkouh, M., Domanski, M., Sleeper, L., Siami, F., Dangas, G., Mack, M., et al. (2012). Strategies for multivessel revascularization in patients with diabetes. New England Journal of Medicine, 367(25) pp. 2375-2384. [Link]
  • Chew, D.P., Mattschoss, S.F., Horsfall, M., Astley, C., Vaile, J. and Joseph, M. (2012). Patterns of inflammatory activation associated with precipitants of acute coronary syndromes: A case-crossover study. Internal Medicine Journal, 42(10) pp. 1096-1103. [10.1111/j.1445-5994.2011.02583.x]
  • Chew, D.P., Brieger, D., Astley, C. and Georgiou, A. (2012). Measuring performance and outcomes of acute coronary syndromes management in Australia. Medical Journal of Australia, 197(3) pp. 140-142. [10.5694/mja11.11259]
  • Chew, D. and Lee, L. (2012). Long-term antiplatelet therapy: from clinical trials to clinical application. Current Opinion in Cardiology, 27(4) pp. 347-354. [10.1097/HCO.0b013e328353fe5c]
  • Chew, D. (2012). Vorapaxar in the Secondary Prevention of Atherothrombotic Events. New England Journal of Medicine, 366(15) pp. 1404-1413. [10.1056/NEJMoa1200933]
  • Bertaso, A., Richardson, J., Wong, D., Cunnington, M., Nelson, A., Tayeb, H., et al. (2012). Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population. International Journal of Cardiology, [10.1016/j.ijcard.2012.05.051]
  • Abizaid, A., Costa, J., Banning, A., Bartorelli, A., Dzavik, V., Ellis, S., et al. (2012). The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. JACC: Cardiovascular Interventions, 5(1) pp. 64-71. [Link]
  • Lee, L. and Chew, D. (2012). Promise of factor Xa inhibition in acute coronary syndromes. Current Cardiology Reports, 14(1) pp. 40-48. [Link]
  • Wong, D.T., Leung, M., Das, R., Puri, R.K., Liew, G.Y.H., Teo, K.S.L., et al. (2012). Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: Insights from a cardiac MRI study. Catheterization and Cardiovascular Interventions, 80(5) pp. 746-753. [10.1002/ccd.23455]
  • White, H.D., Chew, D.P., Dauerman, H.L., Mahaffey, K., Gibson, C.M., Stone, G.W., et al. (2012). Reduced immediate ischemic events with cangrelor in PCI: A pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. American Heart Journal, 163(2) pp. 182-190. [10.1016/j.ahj.2011.11.001]
  • Reid, C., Ademi, Z., Nelson, M., Connor, G., Chew, D., Shiel, L., et al. (2012). Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis: On behalf of the REACH Registry Investigators. MJA Medical Journal of Australia, 196(3) pp. 193-197. [Link]
  • Perry, R., Joseph, M., Chew, D.P., Aylward, P.E. and De Pasquale, C.G. (2012). Predictors of statin-induced regression of left anterior descending coronary artery wall thickness as measured by high-resolution transthoracic echocardiography. Echocardiography-A Journal of Cardiovascular Ultrasound and Allied Techniques, 29(6) pp. 641-646. [10.1111/j.1540-8175.2012.01667.x]
  • Malkin, C., Prakash, R. and Chew, D. (2012). The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry. BMJ Open, 2(1) [Link]
  • Alasady, M., Abhayaratna, W., Leong, D.P.Y., Lim, H.S., Abed, H.S., Brooks, A., et al. (2011). Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm, 8(7) pp. 955-960. [10.1016/j.hrthm.2011.02.016]
  • Astley, C., MacDougall, C., Davidson, P. and Chew, D. (2011). Lost in Translation: Health Resource Variability in the Achievement of Optimal Performance and Clinical Outcome. Circulation: Cardiovascular Quality and Outcomes, 4(5) pp. 512-520. [10.1161/CIRCOUTCOMES.110.960229]
  • Urban, P., Abizaid, A., Banning, A., Bartorelli, A., Baux, A., Dzavik, V., et al. (2011). Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. Journal of The American College of Cardiology, 57(13) pp. 1445-1454. [Link]
  • Perry, R., De Pasquale, C.G., Chew, D.P., McGavigan, A.D. and Joseph, M. (2011). Tissue Doppler derived mechanical dyssynchrony does not change after cardiac resynchronization therapy. Echocardiography-A Journal of Cardiovascular Ultrasound and Allied Techniques, 28(9) pp. 961-967. [10.1111/j.1540-8175.2011.01498.x]
  • Patel, M., Smalling, R., Thiele, H., Barnhart, H., Zhou, Y., Chandra, P., et al. (2011). Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: The CRISP AMI Randomized Trial. JAMA-Journal of The American Medical Association, 306(12) pp. 1329-1337. [Link]
  • Kalahasti, V., Chew, D.P., Nambi, V., Minor, S.G., Zuzek, R., Ellis, S.G., et al. (2011). Influence of metabolic syndrome on outcome after percutaneous coronary intervention. Interventional Cardiology, 3(6) pp. 721-726. [10.2217/ica.11.80]
  • Joseph, M., R, P., Sinhal, A., Chew, D., Carlson, S. and Webb, J. (2011). Acute mitral regurgitation complicating transcatheter aortic valve implantation. JOURNAL OF HEART VALVE DISEASE, 20(3) pp. 361-363. [Link]
  • Chew, D., Aroney, C., Aylward, P., White, H., Kelly, A., Tideman, P., et al. (2011). 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the Management of Acute Coronary Syndromes (ACS) 2006. Heart, Lung and Circulation, 20(8) pp. 487-502. [Link]
  • Bhatt, D., Chew, D., Hirsch, A., Ringleb, P., Hacke, W. and Topol, E. (2011). Superiority Of Clopidogrel Versus Aspirin In Patients With Prior Cardiac Surgery. Circulation, 103(3) pp. 363-368. [Link]
  • Astley, C., Tonkin, A.M., Mahar, L.J., Davidson, P., Boyden, A., Brieger, D., et al. (2011). Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborative. Internal Medicine Journal, 41(2) pp. 206-210. [10.1111/j.1445-5994.2010.02415.x]
  • Behan, M.W., Holm, N.R., Curzen, N.P., Erglis, A., Stables, R.H., de Belder, A.J., et al. (2011). Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circulation: Cardiovascular Interventions, 4 pp. 57-64. [10.1161/CIRCINTERVENTIONS.110.958512]
  • Huynh, L., Rankin, J., Tideman, P.A., Brieger, D., Erickson, M., Markwick, A.J., et al. (2010). Reperfusion therapy in the acute management of ST-segment-elevation myocardial infarction in Australia: findings from the ACACIA registry. MJA Medical Journal of Australia, 193(09) pp. 496-501. [Link]
  • Medi, C., Chew, D.P., Amerena, J., Coverdale, S., Soman, A., Astley, C., et al. (2010). An Invasive Management Strategy is Associated with Improved Outcomes in High-Risk Acute Coronary Syndromes in Patients with Chronic Kidney Disease. Internal Medicine Journal, [DOI: 10.1111/j.1445-5994.2010.02361.x]
  • Serebruany, V., Floyd, J. and Chew, D. (2010). Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook. American Journal of Therapeutics, [Link]
  • Brieger, D., Aroney, C., Chew, D., Kelly, A., Walters, D., Toohey, C., et al. (2010). Acute coronary syndromes: consensus recommendations for translating knowledge into action. MJA Medical Journal of Australia, 192(12) pp. 700-701. [Link]
  • Behan, M.W., Chew, D.P. and Aylward, P.E. (2010). The role of antiplatelet therapy in the secondary prevention of coronary artery disease. Current Opinion in Cardiology, 25(4) pp. 321-328. [doi: 10.1097/HCO.0b013e328338f7b5]
  • Chew, D.P., Anderson, F.A., Avezum, A., Eagle, K.A., FitzGerald, G., Gore, J.M., et al. (2010). Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes. E-Heart, 96(15) pp. 1201-1206. [doi:10.1136/hrt.2009.184853]
  • Chew, D.P., Carter, R., Rankin, B., Boyden, A. and Egan, H. (2010). Cost effectiveness of a general practice chronic disease management plan for coronary heart disease in Australia. Australian Health Review, 34(2) pp. 162-169. [doi:10.1071/AH09742]
  • Wong, Y.W., Prakash, R. and Chew, D.P. (2010). Antiplatelet therapy in percutaneous coronary intervention: recent advances in oral antiplatelet agents. Current Opinion in Cardiology, 25(4) pp. 305-311. [10.1097/HCO.0b013e328339f1aa]
  • Ademi, Z., Liew, D., Chew, D.P., Conner, G., Shiel, L., Nelson, M.R., et al. (2009). Drug Treatment and Cost of Cardiovascular Disease in Australia. Cardiovascular Therapeutics, 27(3) pp. 164-172. [DOI: 10.1111/j.1755-5922.2009.00090.x]
  • Bhatt, D.L., Lincoff, A.M., Gibson, C.M., Stone, G.W., McNulty, S., Montalescot, G., et al. (2009). Intravenous Platelet Blockade with Cangrelor during PCI. New England Journal of Medicine, 361(24) pp. 2330-2341. [doi:10.1056/nejmoa0908629]
  • Brieger, D., Kelly, A., Aroney, C.N., Tideman, P.A., Freedman, S.B., Chew, D.P., et al. (2009). Acute coronary syndromes: consensus recommendations for translating knowledge into action. MJA Medical Journal of Australia, 191(6) pp. 334-338. [Link]
  • Chew, D.P. and Astley, C. (2009). The value of "more" information: the emerging role of novel diagnostic investigations in cardiovascular medicine. Heart, Lung and Circulation, 18(2) pp. 114-117. [doi:10.1016/j.hlc.2008.11.005]
  • Chew, D.P. and Blows, L.J.H. (2009). Randomized trials of clinical networks in the management of ST-elevation MI: can they be performed? Current Opinion in Cardiology, 24(4) pp. 301-306.
  • Chew, D.P., Huynh, L.T., Liew, D., Astley, C., Soman, A. and Brieger, D. (2009). Potential survival gains in the treatment of myocardial infarction. Heart, 95 pp. 1844-1850. [doi:10.1136/hrt.2009.174276]
  • Harrington, R.A., Stone, G.W., McNulty, S., White, H.D., Lincoff, A.M., Gibson, C.M., et al. (2009). Platelet Inhibition with Cangrelor in Patients Undergoing PCI. New England Journal of Medicine, 361(24) pp. 2318-2329. [doi:10.1056/nejmoa0908628]
  • Hung, J., Brieger, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C., et al. (2009). Treatment disparities and effect on late mortality in patients with diabetes presenting with acute myocardial infarction: observations from the ACACIA registry. Medical Journal of Australia, 191(10) pp. 539-543. [Link]
  • Huynh, L., Chew, D.P., Sladek, R., Phillips, P.A., Brieger, D. and Zeitz, C.J. (2009). Unperceived treatment gaps in acute coronary syndromes. International Journal of Clinical Practice, 63(10) pp. 1456-1464. [doi:10.1111/j.1742-1241.2009.02182.x]
  • Joynt, K.E., Huynh, L., Amerena, J., Brieger, D., Coverdale, S.G., Rankin, J.M., et al. (2009). Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes. Heart, 95(17) pp. 1442-1448. [doi:10.1136/hrt.2008.154781]
  • Lau, D.H., Huynh, L.T., Chew, D.P., Astley, C., Soman, A. and Sanders, P. (2009). Prognostic impact of types of atrial fibrillation in acute coronary syndromes. American Journal of Cardiology, 104(10) pp. 1317-1323. [doi:10.1016/j.amjcard.2009.06.055]
  • Lehman, S.J., Baker, R.A., Aylward, P.E., Knight, J.L. and Chew, D.P. (2009). Outcomes of cardiac surgery in Indigenous Australians. Medical Journal of Australia, 190(10) pp. 588-593.
  • Ranasinghe, I., Chew, D., Aroney, C., Coverdale, S., Allen, R., Walters, D., et al. (2009). Differences in Treatment and Management of Indigenous and Non-Indigenous Patients Presenting with Chest Pain: Results of the Heart Protection Partnership (HPP) Study. Heart, Lung and Circulation, 18(1) pp. 32-37. [doi:10.1016/j.hlc.2008.08.014]
  • Wallentin, L., Becker, R., Budaj, A., Cannon, C., Emanuelsson, H., Held, C., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 361(11) pp. 1045-1057. [Link]
  • Yong, G., Rankin, J., Ferguson, L., Thom, J., French, J., Brieger, D., et al. (2009). Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the PRACTICAL Trial. American Heart Journal, 157(1) pp. 60.e1-60.e9. [doi:10.1016/j.ahj.2008.09.024]
  • Aroney, C.N., Aylward, P.E., Chew, D.P., Huang, N., Kelly, A., White, H.D., et al. (2008). 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006. Medical Journal of Australia, 188(5) pp. 302-303.
  • Astley, C., Chew, D.P., Aylward, P.E., Molloy, D.A. and De Pasquale, C.G. (2008). A randomised study of three different informational aids prior to coronary angiography, measuring patient recall, satisfaction and anxiety. Heart, Lung and Circulation, 17(1) pp. 25-32. [doi:10.1016/j.hlc.2007.04.008]
  • Worthley, S.G., Helfta, G., Corti, R., Worthley, M.I., Chew, D.P., Fayad, Z.A., et al. (2008). Statin therapy alone and in combination with an Acyl-CoA: cholesterol O-Acyltransferase inhibitor on experimental Atherosclerosis. Pathophysiology of Haemostasis and Thrombosis, 36(1) pp. 9-17. [doi:10.1159/000112634]
  • White, H.D., Chew, D.P., Hoekstra, J., Miller, C.D., Pollack, C.V., Feit, F., et al. (2008). Safety and efficacy of switching from either unfractionated Heparin or Enoxaparin to Bivalirudin in patients with Non-ST-Segment elevation acute coronary syndromes managed with an invasive strategy. Results from the ACUITY trial. Journal of The American College of Cardiology, 51(18) pp. 1734-1741. [doi:10.1016/j.jacc.2007.12.052]
  • Walters, D.L., Aroney, C.N., Chew, D.P., Bungey, L., Coverdale, S., Allan, R., et al. (2008). Variations in the application of cardiac care in Australia. MJA Medical Journal of Australia, 188(4) pp. 218-223.
  • Chew, D. (2008). The last mile: improving patient outcomes within modern cardiovascular medicine. Heart, Lung and Circulation, 17(4) pp. S10-S13. [Link]
  • Chew, D.P., Amerena, J., Coverdale, S., Rankin, J., Astley, C., Soman, A., et al. (2008). Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. MJA Medical Journal of Australia, 188(12) pp. 691-697.
  • Chew, D.P., Huang, Z., Pieper, K.S., White, H.D., Mahaffey, K., Ferguson, J.J., et al. (2008). Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy. American Heart Journal, 155(2) pp. 239-244. [doi:10.1016/j.ahj.2007.10.002]
  • Chew, D.P., Mahaffey, K., White, H.D., Huang, Z., Hoekstra, J., Ferguson, J.J., et al. (2008). Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict. American Heart Journal, 155(5) pp. 841-847. [doi:10.1016/j.ahj.2007.12.002]
  • Lincoff, A., Steinhubl, S., Manoukian, S., Chew, D., Pollack, C., Feit, F., et al. (2008). Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization. JACC: Cardiovascular Interventions, 1(6) pp. 639-648. [Link]
  • Perry, R., De Pasquale, C.G., Chew, D.P. and Joseph, M. (2008). Assessment of early diastolic left ventricular function by two-dimensional echocardiographic speckle tracking. European Journal of Echocardiography, 9(6) pp. 791-795. [doi:10.1093/ejechocard/jen148]
  • Perry, R., De Pasquale, C.G., Chew, D.P., Brown, L., Aylward, P.E. and Joseph, M. (2008). Changes in left anterior descending coronary artery wall thickness detected by high resolution transthoracic echocardiography. American Journal of Cardiology, 101(7) pp. 937-940. [doi:10.1016/j.amjcard.2007.11.053]
  • Perry, R., Joseph, M., De Pasquale, C.G., Chew, D.P., Yiu, D., Aylward, P.E., et al. (2008). High-resolution transthoracic echocardiography of the left anterior descending coronary artery: a novel noninvasive assessment of coronary vasoreactivity. Journal of The American Society of Echocardiography, 21(2) pp. 134-138. [doi:10.1016/j.echo.2007.05.019]
  • Reid, C.M., Nelson, M.R., Shiel, L., Chew, D.P., Connor, G. and Delooze, F. (2008). Australians at Risk: Management of Cardiovascular Risk Factors in the REACH Registry. Heart, Lung and Circulation, 17(2) pp. 114-118. [doi:10.1016/j.hlc.2007.07.009]
  • Sladek, R., Bond, M.J., Huynh, L., Chew, D.P. and Phillips, P.A. (2008). Thinking styles and doctors' knowledge and behaviours relating to acute coronary syndrome guidelines. Implementation Science, 3(23) [doi:10.1186/1748-5908-3-23]
  • Teo, K.S., Carbone, A., Piantadosi, C., Chew, D.P., Hammett, C.J., Brown, M.A., et al. (2008). Cardiac MRI assessment of left and right ventricular parameters in healthy Australian normal volunteers. Heart, Lung and Circulation, 17(4) pp. 313-317. [doi:10.1016/j.hlc.2007.11.136]
  • Bhatt, D.L., Chew, D.P., Grines, C., Mukherjee, D., Leesar, M., Gilchrist, I.C., et al. (2007). Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization-results of the PPAR study. American Heart Journal, 154(1) pp. 137-143. [doi:10.1016/j.ahj.2007.03.029]
  • Huynh, L., Phillips, P.A. and Chew, D.P. (2007). Improving the management of acute coronary syndromes in Australia: translating evidence to outcomes. Internal Medicine Journal, 37(6) pp. 412-415. [doi:10.1111/j.1445-5994.2007.01373.x]
  • Feit, F., Voeltz, M.D., Attubato, M.J., Lincoff, A.M., Chew, D.P., Bittl, J.A., et al. (2007). Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. American Journal of Cardiology, 100(9) pp. 1364-1369. [doi:10.1016/j.amjcard.2007.06.026]
  • Chew, D.P., Amerena, J., Coverdale, S., Rankin, J., Astley, C. and Brieger, D. (2007). Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Internal Medicine Journal, 37(11) pp. 741-748. [doi:10.1111/j.1445-5994.2007.01435.x]
  • Shishehbor, M.H., Lauer, M.S., Singh, I.M., Chew, D.P., Karha, J., Brener, S.J., et al. (2007). In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? Journal of The American College of Cardiology, 49(8) pp. 849-854. [doi:10.1016/j.jacc.2006.10.054]
  • Ajani, A., Szto, G., Duffy, S., Eccleston, D., Clark, D., Lefkovits, J., et al. (2006). The Foundation and Launch of the Melbourne Interventional Group: A Collaborative Interventional Cardiology Project. Heart, Lung and Circulation, 15(1) pp. 44-47. [doi:10.1016/j.hlc.2005.08.001]
  • Chacko, M., Lincoff, A.M., Wolski, K., Cohen, D.J., Bittl, J.A., Lansky, A.J., et al. (2006). Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the randomized evaluation in PCI linking angiomax to reduced clinical events (REPLACE)-2 trial. American Heart Journal, 151(5) pp. 1032.e1-1032.e7. [doi:10.1016/j.ahj.2006.02.012]
  • White, H.D., Kleiman, N.S., Mahaffey, K.W., Lokhnygina, Y., Pieper, K.S., Chiswell, K., et al. (2006). Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the SYNERGY trial. American Heart Journal, 152(6) pp. 1042-1050. [doi:10.1016/j.ahj.2006.08.002]
  • Perry, R., De Pasquale, C.G., Chew, D.P., Aylward, P.E. and Joseph, M. (2006). QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heath failure. Journal of The American Society of Echocardiography, 19(10) pp. 1257-1263. [doi:10.1016/j.echo.2006.04.040]
  • Lehman, S. and Chew, D.P. (2006). Bivalirudin in percutaneous coronary intervention. Vascular Health and Risk Management, 2(4) pp. 357-363. [Link]
  • Chew, D.P., Bhatt, D.L., Lincoff, A.M., Wolski, K. and Topol, E.J. (2006). Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk. Heart, 92(7) pp. 945-950. [doi:10.1136/hrt.2005.078758]
  • Chew, D.P., Astley, C., Molloy, D.A., Vaile, J., De Pasquale, C.G. and Aylward, P.E. (2006). Morbidity, mortality and economic burden of renal impairment in cardiac intensive care. Internal Medicine Journal, 36(3) pp. 185-192. [doi:10.1111/j.1445-5994.2006.01012.x]
  • Chew, D., Bhatt, D., Lincoff, A., Wolski, K. and Topol, E. (2006). Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk. Heart, 92(7) pp. 945-950. [Link]
  • Chew, D., Astley, C., Molloy, D., Vaile, J., De Pasquale, C. and Aylward, P. (2006). The Morbidity, Mortality and Economic Burden of Renal Impairment in Cardiac Intensive Care. Internal Medicine Journal, 36(3) pp. 185-192. [Link]
  • Chew, D. and White, H. (2006). Immediate Pharmacology in the current era of reperfusion therapy. US Cardiology, 3(2) pp. 1-4. [Link]
  • Chen, M.S., John, J.M., Chew, D.P., Lee, D.S., Ellis, S.G. and Bhatt, D.L. (2006). Bare metal stent restenosis is not a benign clinical entity. American Heart Journal, 151(6) pp. 1260-1264. [doi:10.1016/j.ahj.2005.08.011]
  • Chen, M.S., Bhatt, D.L., Chew, D.P., Moliterno, D.J., Ellis, S.G. and Topol, E.J. (2005). Outcomes in African Americans and whites after percutaneous coronary intervention. American Journal of Medicine, 118(9) pp. 1019-1025. [doi:10.1016/j.amjmed.2004.12.035]
  • Chew, D., Aylward, P. and White, H. (2005). Facilitated percutaneous coronary intervention: Is this strategy ready for implementation? Current Cardiology Reports, 7(4) pp. 235-241. [DOI:10.1007/s11886-005-0043-1]
  • Fathi, R.B., Gurm, H., Chew, D.P., Gupta, R., Bhatt, D.L. and Ellis, S.G. (2005). The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutanous coronary intervention. American Heart Journal, 150(6) pp. 1190-1197. [doi:10.1016/j.ahj.2005.01.031]
  • Gupta, R., Gurm, H., Bhatt, D.L., Chew, D.P. and Ellis, S.G. (2005). Renal failure after percutaneous coronary intervention is associated with high mortality. Catheterization and Cardiovascular Interventions, 64(4) pp. 442-448.
  • Ebrahimi, R., Lincoff, A.M., Bittl, J.A., Chew, D.P., Wolski, K., Wadhan, N., et al. (2005). Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis. Journal of Cardiovascular Pharmacology and Therapeutics, 10(4) pp. 209-216. [doi:10.1177/107424840501000401]
  • Chew, D.P., Lincoff, A.M., Gurm, H., Wolski, K., Cohen, D.J., Henry, T., et al. (2005). Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial) American Journal of Cardiology, 95(5) pp. 581-585. [doi:10.1016/j.amjcard.2004.11.003]
  • Chew, D.P., Allan, R.M., Aroney, C.N. and Sheerin, N.J. (2005). National data elements for the clinical management of acute coronary syndromes. Medical Journal of Australia, 182(9) pp. S5-S14.
  • Koster, A., Spiess, B.D., Chew, D.P., Krabatsch, T., Tambeur, L., Deanda, A., et al. (2004). Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. American Journal of Cardiology, 93(3) pp. 356-359. [doi:10.1016/j.amjcard.2003.10.021]
  • Koster, A., Chew, D.P., Merkle, F., Gruendel, M., Jurmann, M., Kuppe, H., et al. (2004). Extracorporeal elimination of large concentrations of tirofiban by zero-balanced ultrafiltration during cardiopulmonary bypass; an in vitro investigation. Anesthesia and Analgesia, 99(4) pp. 989-992. [doi:10.1213/01.ANE.0000131509.94879.FB]
  • Lincoff, A.M., Bittl, J.A., Kleiman, N.S., Sarembock, I.J., Jackman, J.D., Mehta, S., et al. (2004). Comparison of Bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to reduced clinical events [REPLACE]-1 trial) American Journal of Cardiology, 93(9) pp. 1092-1096. [doi:10.1016/j.amjcard.2004.01.033]
  • Quinn, M.J., Bhatt, D.L., Zidar, F., Vivekananthan, D., Chew, D.P., Ellis, S.G., et al. (2004). Effect of clopidogrel pretreatment on inflammatory marker expression inpatients undergoing percutaneous coronary intervention. American Journal of Cardiology, 93(6) pp. 679-684. [doi:10.1016/j.amjcard.2003.11.048]
  • Bittl, J.A., Chew, D.P., Topol, E.J., Kong, D.F. and Califf, R.M. (2004). Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty verses atherectomy, cutting balloon atherotomy, or laser angioplasty. Journal of The American College of Cardiology, 43(6) pp. 936-942. [doi:10.1016/j.jacc.2003.10.039]
  • Chen, M.S., Bhatt, D.L., Mukherjee, D., Chan, A.W., Roffi, M., Kapadia, S.R., et al. (2004). Feasibility of simultaneous bilateral carotid artery stenting. Catheterization and Cardiovascular Interventions, 61(4) pp. 437-442. [Link]
  • De Pasquale, C.G., Arnolda, L.F., Aylward, P.E., Chew, D.P. and Bersten, A.D. (2004). Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation, 110(9) pp. 1091-1096. [doi:10.1161/01.CIR.0000140260.73611.FA]
  • Vivekananthan, D.P., Bhatt, D.L., Chew, D.P., Zidar, F.J., Chan, A.W., Moliterno, D.J., et al. (2004). Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. American Journal of Cardiology, 94(3) pp. 358-360. [doi:10.1016/j.amjcard.2004.04.035]
  • Bhatt, D.L., Chew, D.P., Lincoff, A.M., Simoons, M.L., Harrington, R.A., Ommen, S.R., et al. (2003). Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. American Journal of Cardiology, 92(2) pp. 136-140. [doi:10.1016/S0002-9149(03)00527-7]
  • Casserly, I.P., Topol, E.J., Jia, G., Hamm, C., Meier, , Di Battiste, P.M., et al. (2003). Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - observations from the TARGET trial. American Journal of Cardiology, 92(2) pp. 125-129. [DOI:10.1016/S0002-9149(03)00525-3]
  • Chan, A.W., Bhatt, D.L., Chew, D.P., Reginelli, J., Schneider, J.P., Topol, E.J., et al. (2003). Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation, 107(13) pp. 1750-1756. [doi:10.1161/01.CIR.0000060541.18923.E9]
  • Chew, D.P., Bhatt, D.L., Kimball, W., Henry, T., Berger, P., Mccullough, P.A., et al. (2003). Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. American Journal of Cardiology, 92(8) pp. 919-923. [doi:10.1016/S0002-9149(03)00970-6]
  • Cho, L., Chew, D.P., Moliterno, D.J., Roffi, M., Ellis, S.G., Franco, I., et al. (2003). Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. American Journal of Cardiology, 91(6) pp. 742-743. [doi:10.1016/S0002-9149(02)03420-3]
  • Koster, A., Chew, D.P., Grundel, M., Bauer, M., Kuppe, H. and Spiess, B.D. (2003). Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesthesia and Analgesia, 96(2) pp. 383-386. [doi:10.1097/00000539-200302000-00015]
  • Koster, A., Chew, D.P., Grundel, M., Haussman, H., Grauhan, O., Kuppe, H., et al. (2003). An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study. Anesthesia and Analgesia, 96(5) pp. 1316-1319. [doi:10.1213/01.ANE.0000057605.61063.55]
  • Koster, A., Chew, D.P., Kuebler, W., Habazetti, H., Bauer, M., Haussman, H., et al. (2003). Effects of tirofiban on hemostatic activation and inflammatory response during cardiopulmonary bypass. American Journal of Cardiology, 91(3) pp. 346-347. [doi:10.1016/S0002-9149(02)03167-3]
  • Koster, A., Chew, D.P., Kuebler, W., Habazetti, H., Hetzer, R. and Kuppe, H. (2003). High antithrombin III levels attentuate hemostatic activation and leukocyte activation during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 126(3) pp. 906-907. [doi:10.1016/S0022-5223(03)00392-1]
  • Yen, M.H., Bhatt, D.L., Chew, D.P., Harrington, R.A., Newby, L.K., Ardissino, D., et al. (2003). Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. American Journal of Medicine, 115(4) pp. 318-321. [doi:10.1016/S0002-9343(03)00358-9]
  • Chan, A., Bhatt, D., Chew, D., Quinn, M., Moliterno, D., Topol, E., et al. (2002). Early and Sustained Survival Benefit associated with Statin therapy at the time of Percutaneous Coronary Intervention. Circulation, 105 pp. 691-696. [Link]
  • Chan, A., Chew, D., Bhatt, D., Moliterno, D., Topol, E. and Ellis, S. (2002). Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction: A 7-year prospective analysis. American Journal of Cardiology, 89(2) pp. 132-136. www.ajconline.org/article/S0002-9149(01)02188-9/abstract.
  • White, H. and Chew, D. (2002). Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions. EXPERT OPINION ON PHARMACOTHERAPY, 3(6) pp. 777-788. [Link]
  • White, H. and Chew, D. (2002). Bivalirudin, a thrombin-specific anticoagulant for unstable angina and coronary interventions. Drugs,
  • Tamberella, M., Bhatt, D., Chew, D., Kereiakes, D., Topol, E. and Steinhubl, S. (2002). Relation of Platelet Inactivation with Intravenous GP IIb/IIIa Antagonists To Major Bleeding: (from the GOLD Study) American Journal of Cardiology, 89(12) pp. 1429-1431. [Link]
  • Roffi, M., Mukherjee, D., Chew, D., Bhatt, D., Cho, L., Robbins, M., et al. (2002). Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition As Adjunctive Treatment For Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis Of Five Randomized Trials. Circulation, 106 pp. 3063-3067. [Link]
  • Roffi, M., Chew, D., Mukherjee, D., Bhatt, D., White, J., Heeschen, C., et al. (2002). Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. European Heart Journal, 23(18) pp. 1441-1448. [Link]
  • Reginelli, J. and Chew, D. (2002). Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Cardiology in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition. Journal of Interventional Cardiology, 15(2) pp. 141-146. [Link]
  • Jeremias, A., Bhatt, D., Chew, D., Ziada, K., Albirini, A., Brener, S., et al. (2002). Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. American Journal of Cardiology, 89(10) pp. 1209-1211. [Link]
  • Jeremias, A., Albirini, A., Ziada, K., Chew, D., Brener, S., Topol, E., et al. (2002). Prognostic Significance of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention in Patients with Chronic Renal Dysfunction. American Heart Journal, 143(6) pp. 1040-1045. [Link]
  • Ellis, S., Chew, D., Chan, A., Whitlow, P., Schneider, J. and Topol, E. (2002). Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation, 106(10) pp. 1205-1210. [Link]
  • Chew, D., Moliterno, D. and Herrmann, H. (2002). Present and Potential Future Paradigms for the Treatment of ST-Segment Elevation Acute Myocardial Infarction. Journal of Invasive Cardiology, 14(2) [Link]
  • Chew, D. and Moliterno, D. (2002). Managing Unstable Angina in High-Risk Patients. Journal of Invasive Cardiology, 14(2) [Link]
  • Chew, D. and Bhatt, D. (2002). Optimizing Glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. Internal Medicine Journal, 32(7) pp. 338-345. [Link]
  • Chew, D. (2002). Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures. Hamostaseologie, 22(3) pp. 60-66. [Link]
  • Chan, A., Quinn, M., Bhatt, D., Chew, D., Moliterno, D., Topol, E., et al. (2002). Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. Journal of The American College of Cardiology, 40(4) pp. 669-675. [Link]
  • Bhatt, D., Chew, D. and Topol, E. (2001). The importance of intravenous antiplatelet therapy with abciximab during percutaneous coronary intervention in diabetic patients. Cardiovascular Reviews and Reports, 22(3) pp. 161-164. [Link]
  • Chew, D., Bhatt, D., Sapp, S. and Topol, E. (2001). Increased Mortality with Oral Platelet Glycoprotein IIb/IIIa Antagonists: A Meta-analysis of the Phase III Multi-center Randomized Trials. Circulation, 103(2) pp. 201-206. [Link]
  • Bhatt, D., Kapadia, S., Chew, D., Ziada, K., Mukherjee, D., Roffi, M., et al. (2001). Dual anti-platelet therapy with clopidogrel and aspirin after carotid stenting. Journal of Invasive Cardiology, 13(12) pp. 767-771. [Link]
  • Chan, A., Chew, D. and Lincoff, A. (2001). Update on Pharmacology for Restenosis. Current Interventional Cardiology Reports, 3(2) pp. 149-155. [Link]
  • Roffi, M., Chew, D., Mukherjee, D., Bhatt, D., White, J., Heeschen, C., et al. (2001). Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndromes. Circulation, 104(23) pp. 2767-2771. [Link]
  • Mukherjee, D., Chew, D., Robbins, M., Yadav, J., Raymond, R. and Moliterno, D. (2001). Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk. Journal of Thrombosis and Thrombolysis, 11(2) pp. 151-154. [Link]
  • Chew, D., Roffi, M. and Topol, E. (2001). Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes. Progress in Cardiovascular Diseases, 44(3) pp. 195-206. [Link]
  • Chew, D., Robbins, M., Bhatt, D., Penn, M., Schneider, J., Lauer, M., et al. (2001). Incremental Prognostic Value of Elevated Baseline C-reactive Protein among Established Markers of Risk in Percutaneous Coronary Intervention. Circulation, 104(9) pp. 992-997. [Link]
  • Chew, D., Bhatt, D., Robbins, M., Mukherjee, D., Roffi, M., Schneider, J., et al. (2001). Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. American Journal of Cardiology, 88(6) pp. 672-674. [Link]
  • Chew, D., Bhatt, D., Lincoff, A., Moliterno, D., Brener, S., Wolski, K., et al. (2001). Defining the Optimal Activated Clotting Time During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials. Circulation, 103 pp. 961-966. [Link]
  • Chew, D., Bhatt, D. and Topol, E. (2001). Oral glycoprotein IIb/IIIa inhibitors: why don't they work? American Journal of Cardiovascular Drugs, 1(6) pp. 421-428. [Link]
  • Chew, D. and Moliterno, D. (2001). GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us. CLEVELAND CLINIC JOURNAL OF MEDICINE, 68(12) pp. 1017-1023. [Link]
  • Chew, D. and Bhatt, D. (2001). Oral glycoprotein IIb/IIIa antagonists in coronary artery disease. Current Cardiology Reports. Current Cardiology Reports, 3(1) pp. 63-71. [Link]
  • Chew, D. and Moliterno, D. (2000). A critical appraisal of platelet glycoprotein IIb/IIIa inhibition. Journal of The American College of Cardiology, 36(7) pp. 2028-2035. [Link]
  • Roffi, M., Chew, D., Ziada, K. and Whitlow, P. (2000). Percutaneous Coronary Intervention of Unprotected Left Main Coronary Stenosis. Cardiovascular Medicine,
  • Tonkin, A. and Chew, D. (1999). How Can We Stratify Patients With Unstable Angina And Determine Optimal Therapy? Dialogues in Cardiovascular Medicine, 4(3) pp. 146-158. [Link]
Refereed conference papers
  • Chew, D., Aroney, C., Aylward, P., Kelly, A., White, H., Tideman, P., et al. (2011). 2011 Addendum to the guidelines for the management of acute coronary syndromes 2006. In Heart, Lung and Circulation. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Chong, F., Malkin, C., Penhall, A., Selvanayagam, J., Chew, D., Joseph, M., et al. (2011). Percutaneous balloon aortic valvuloplasty for severe aortic stenosis : haemodynamic evaluation by echocardiography. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Wong, Y., Joseph, M., Chew, D., Bennetts, J., Chong, F., Selvanayagam, J., et al. (2011). Comparison of early haemodynamic performance between transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) bioprosthesis. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Walters, D., Sinhal, A., Barron, D., Pasupati, S., Thambar, S., Yong, G., et al. (2011). Australian and New Zealand Source Registry: Edwards Sapien Transcatheter Aortic Valve Replacement-30 Day Outcomes. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Waddell-Smith, K., Parsonage, W., Arstall, M., Coverdale, S., Prasad, D., Cross, D., et al. (2011). Under-treatment of women with acute coronary syndrome appears to be related to unrecognised risk. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Ranasinghe, I., Freedman, B., Neubeck, L., Aliprandi-Costa, B., Devlin, G., Lefkovits, J., et al. (2011). Temporal change in pre-hospital statin use and total cholesterol levels in patients presenting with acute coronary syndromes. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Prakash, R., Malkin, C., Chew, D., Horsfall, M., Amerena, J., Markwick, A., et al. (2011). The Impact of Advanced Age on Clinical Outcome from an Early Invasive Strategy in Patients with Acute Coronary Syndrome. The Acute Coronary Syndrome Prospective Audit registry (ACACIA) In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Prakash, R., Chew, D., Sinhal, A., Horsfall, M., Green, C., Makoy, D., et al. (2011). Expected survival and value of transcatheter aortic valve implantation (TAVI) versus medical therapy in patients with severe aortic stenosis (AS) based on the Flinders Medical Centre (FMC) comparative dataset. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Penhall, A., Altman, M., Chong, D., Sinhal, A., Selvanayagam, J., Chew, D., et al. (2011). Percutaneous aortic valve replacement results in an acute reduction in mitral regurgitation. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Medi, C., Brieger, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C., et al. (2011). An invasive management strategy is associated with improved outcomes in high risk acute coronary syndromes in patients with chronic kidney disease (CKD) In Internal Medicine Journal. Cardiac Society of Australia and New Zealand. Christchurch, NZ, pp. 743-750. [Link]
  • Markwick, A., Chew, D., Horsfall, M., Dhiantravan, N., San, M., Chou, A., et al. (2011). Outcomes of moderate and severe mitral regurgitation in the modern era : a Flinders Medical Centre (FMC) experience. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Lee, L., Prakash, R., Joseph, M., Green, C., Bennetts, J., Chew, D., et al. (2011). One Year Echocardiographic Follow Up in Patients Treated with Edwards Sapien Aortic Valve Implantation: Experience from the Flinders Medical Centre. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Lee, L., Prakash, R., Joseph, M., Bennetts, J., Puckridge, P., Cheng, W., et al. (2011). Transcatheter aortic valve implantation (TAVI) for severe aortic stenosis, experience from the Flinders Medical Centre. In Heart, Lung and Circulation. Supplement 2 ed. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Costa, B., Ranasinghe, I., Turnbull, F., Antonis, P., Coverdale, S., Brown, A., et al. (2011). Emerging practice patterns in the management of STEMI and high risk ACS-early findings from the CONCORDANCE registry. In Heart, Lung anf Circulation. 59th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Alasady, M., Abhayaratna, W., Leong, D., Lim, H., Barlow, D., Roberts-Thomson, K., et al. (2010). Left atrial structural remodelling as a consequence of myocardial infarction : relationship to adverse cardiovascular outcome. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Wong, D., Chew, D., Cameron, J., Nelson, A., Meredith, I., Worthley, S., et al. (2010). Arterial stiffness predicts myocardial perfusion reserve : an Adenosine stress cardiac magnetic resonance study. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Altman, M., Penhall, A., Perry, R., Sinhal, A., Bennetts, J., Chew, D., et al. (2010). Echocardiographic parameters pre and post transcatheter aortic valve implantation with Edwards Sapien prosthesis. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Astley, C., MacDougall, C. and Chew, D. (2010). Health service variability as determinants of achievement of performance indicators and outcome. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Brennan, A., Dinh, D., Costolloe, C., Johnston, N., McNeil, J., Duffy, S., et al. (2010). Cardiovascular clinical outcome and quality registries - an Australian perspective. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Chew, D., Carter, R. and Boyden, A. (2010). Cost-effectiveness of a general practice chronic disease management plan for coronary heart disease in Australia. In Australia Health Review. Cardiac Society of Australia and New Zealand. Christchurch, NZ, pp. 162-169. [Link]
  • Chew, D., Pasupati, S., Bennetts, J., Baron, D., Kejriwal, N., Walters, D., et al. (2010). The initial 30-day Australian and New Zealand Edwards Sapien aortic valve replacement experience. In Heart, Lung and Circulation. Supplement 19 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Penhall, A., Perry, R., Altman, M., Sinhal, A., Bennetts, J., Chew, D., et al. (2010). Instantaneous decrease in left ventricular afterload during percutaneous aortic valve implantation does not result in immediate changes in left ventricular strain. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Perry, R., Joseph, M., Penhall, A., Brown, L., Chew, D., Aylward, P., et al. (2009). Actual cardiac risk in self deemed 'normal' population. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Sydney, Australia. [Link]
  • Clark, R., Wilkinson, D., Coffee, N., Eckert, K., Astles, P., Milligan, M., et al. (2009). Mapping services to support a patient's journey through evidence-based care pathways after a cardiac event. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Sydney, Australia. [Link]
  • Horsfall, M., Mattschoss, S., Astley, C., Scott, E., Vaile, J., Joseph, M., et al. (2009). Exercise, diet and dental work as precipitants of myocardial infarctions: a case-crossover study. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Sydney, Australia, pp. S258-S259. [Link]
  • Joseph, M., Winter, M., Perry, R., Penhall, A., Carlsen, S., Chew, D., et al. (2009). Clinical utility of a characteristic echocardiographic sign in pulmonary embolism. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Sydney, Australia. [Link]
  • Lehman, S., Chew, D., Brieger, D., Amerena, J., Coverdale, S., Rankin, J., et al. (2009). Management and 12-month outcomes of indigenous Australians presenting with acute coronary syndrome: the ACACIA registry. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Sydney, Australia. [Link]
  • Mattschoss, S., Horsfall, M., Astley, C., Scott, E., Vaile, J., Joseph, M., et al. (2009). Triggering myocardial infarction by infection: A case-crossover study. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Sydney, Australia, pp. S262-S263. [Link]
  • Dundon, B., Huynh, L., Worthley, S., Astley, C., Soman, A., Brieger, D., et al. (2008). Acute coronary syndrome complicated by haemodynamic compromise: improved survival with an invasive management strategy. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia, pp. S109-S110. [Link]
  • Dundon, B., Huynh, L., Worthley, S., Astley, C., Soman, A., Brieger, D., et al. (2008). Successfully resuscitated cardiac arrest is associated with reduced in-hospital, but not long-term survival in acute coronary syndrome. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Simpson, N., Perry, D., Perry, R. and Chew, D. (2008). Short cardiac educational reading improves knowledge base in both cardiac and non-cardiac nursing staff. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Perry, R., Joseph, M., Chew, D., Aylward, P. and De Pasquale, C. (2008). Moderate statin therapy does not change left anterior descending coronary artery wall thickness as measured by high resolution transthoracic echocardiography. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia, pp. S27-S28. [Link]
  • Penhall, A., Perry, R., Mangoni, A., De Pasquale, C., Chew, D. and Joseph, M. (2008). Can speckle tracking assist in the detection of subclinical myocardial changes in hypertensive patients? In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Mattschoss, S., Eccleston, D., Walters, D., Brieger, D., Rankin, J., Astley, C., et al. (2008). Aspirin responsiveness/resistance and diabetes in an acute coronary syndrome (ACS) population. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Lehman, S., Baker, R., Aylward, P., Cullen, H., Worthley, S., Knight, J., et al. (2008). Cardiac surgical outcomes in indigenous Australians: The Flinders Medical Centre registry. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia, pp. S156-S157. [Link]
  • Lau, D., Huynh, L., Chew, D., Astley, C., Soman, A., Young, G., et al. (2008). Time of onset of ventricular arrhythmia in acute coronary syndrome determines its long-term prognostic burden. In Heart, Lung and Circulation. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Lau, D., Huynh, L., Chew, D., Astley, C., Soman, A., Young, G., et al. (2008). Incidence and prognostic impact of new onset atrial fibrillation varies with acute coronary syndrome severity. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Eccleston, D., Brieger, D., Walters, D., Rankin, J., Mattschoss, S., Huynh, L., et al. (2008). Aspirin resistance predicts an increased risk of in-hospital events in Australian patients with acute coronary syndromes: results from the CARS study. In Heart, Lung and Circulation. Supplement 3 ed. Cardiac Society of Australia and New Zealand. Adelaide, Australia. [Link]
  • Amerena, J., Brieger, D., Coverdale, S., Rankin, J., Huynh, L., Astley, C., et al. (2007). The ACACIA Registry - frequency of in-hospital complications and their association with 6-month mortality after acute coronary syndromes (ACS). In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ, pp. S122-S123. [Link]
  • Astley, C., Amerena, J., Brieger, D., Coverdale, S., Rankin, J., Huynh, L., et al. (2007). Identifying the factors contributing to poorer outcome in women in the acute coronary syndromes prospective audit (ACACIA). In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Iyngkaran, P., Perry, R., Bridgman, J., Chew, D., De Pasquale, C. and Joseph, M. (2007). Can exercise stress echocardiography predict ischemic vascular territories accurately? In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, New Zealand.
  • Bridgman, J., Perry, R., Iyngkaran, P., De Pasquale, C., Chew, D. and Joseph, M. (2007). Diastolic function has limited value in predicting age adjusted exercise capacity. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, New Zealand, pp. S31-S31. [Link]
  • Brieger, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C. and Chew, D. (2007). Logistics of ACS management in rural versus metropolitan hospitals. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Brown, A., Chew, D., Beever, W., Weeramanthri, T. and Currie, B. (2007). Quality and outcomes of acute and long term care of indigenous people with acute coronary syndromes: Data from the central Australian secondary prevention of acute coronary syndromes (CASPA) study. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ.
  • Chew, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C. and Brieger, D. (2007). Management and outcomes for acute coronary syndromes in Australia: Observations from the acute coronary syndromes prospective audit (ACACIA). In Heart, Lung and Circulation. Cardiac Society of Australia and New Zealand. Christcurch, NZ. [Link]
  • Coverdale, S., Brieger, D., Amerena, J., Rankin, J., Astley, C. and Chew, D. (2007). Distance and invasive services for acute coronary syndromes in Australia. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ, pp. S120-S121. [Link]
  • Duncan, R., Eling, V., Brown, M., Carbone, A., Chew, D., Korlaet, M., et al. (2007). Outcomes and diagnostic accuracy of 16-slice multi-detector computed tomography angiography in symptomatic patients with a non-diagnostic stress test. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, New Zealnd, pp. 36-37. [Link]
  • Erickson, M., Rankin, J., Amerena, J., Brieger, D., Coverdale, S., Huynh, L., et al. (2007). Reperfusion therapy in STEMI: ACACIA registry contemporary Australian data. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Hung, J., Chew, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C., et al. (2007). Implications of diabetes in patients with acute coronary syndromes (ACS). Experience from the ACACIA (Australian Acute Coronary Syndromes Prospective Audit) Registry. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Huynh, L., Astley, C., Amerena, J., Brieger, D., Coverdale, S., Rankin, J., et al. (2007). The relative and absolute impact of therapies for acute coronary syndrome (ACS) on 6 month events: a nested case-control analysis of the Australian Collaborative Acute Coronary Syndromes Prospective Audit (ACACIA). In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ, pp. S126-S127. [Link]
  • Huynh, L., Zeitz, C., Phillips, P., Amerena, J., Brieger, D., Coverdale, S., et al. (2007). Factors predicting high-risk acute coronary syndrome: how do clinicians rank them? In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Iyngkaran, P., Perry, R., Bersten, A., De Pasquale, C., Chew, D., Joseph, M., et al. (2007). Estimation of pulmonary artery pressures in intensive care patients using both continuous and pulsed wave Doppler. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Worthley, M., Juergens, C., Amerena, J., Coverdale, S., Rankin, J., Worthley, S., et al. (2007). A 6-month follow-up comparison of drug eluting with bare metal stents in the treatment of acute coronary syndromes: on behalf of Australian Acute Coronary Syndromes Prospective Audit (ACACIA) Study Investigators. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Reid, C., Nelson, M., Connor, G., Chew, D., Shiel, L. and De Looze, F. (2007). Risk Factor Control in Patients at High-Risk of Atherothrombosis in Australian General Practice-Local Results from the Reach Registry. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Ranasinghe, I., Chew, D., Walters, D. and Brieger, D. (2007). Differences in treatment and management of indigenous and non-indigenous patients presenting with chest pain: Heart Protection Partnership (HPP) Study. In Heart, Lung and Circulation. Cardiac Society of Australia and New Zealand. Christchurch, NZ, pp. 32-37. [Link]
  • Perry, R., De Pasquale, C., Chew, D. and Joseph, M. (2007). Level of tissue Doppler derived mechanical dyssynchrony does not change after cardiac resynchronization therapy. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Penhall, A., Perry, R., De Pasquale, C., Chew, D. and Joseph, M. (2007). Regional variation of two dimensional circumferential strain in normal patients using echocardiography. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Lehman, S., Aylward, P., Worthley, S., Dalton, A. and Chew, D. (2007). Coronary calcium scoring for the screening of cardiovascular disease in intermediate risk patients: A decision analysis approach. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [Link]
  • Hecker, T., De Pasquale, C., Minson, R., Koutsounis, H., Brown, L., Perry, R., et al. (2006). Side effects of high dose dobutamine are not prevented by normal saline infusion in dobutamine stress echocardiography. In Echocardiography. Cardiac Society of Australia and New Zealand. Canberra, pp. 712-716. [Link]
  • Perry, R., Yiu, D., Joseph, M., De Pasquale, C., Chew, D., Aylward, P., et al. (2006). High resolution transthoracic echocardiography assessment of the left anterior descending coronary artery: a novel and non-invasive approach to study coronary vasomotion in humans. In Journal of the American Society of Echocardiography. Cardiac Society of Australia and New Zealand. Canberra, Australia, pp. 134-138. [Link]
  • Chew, D., Bhatt, D., Lincoff, A., Wolski, K. and Topol, E. (2005). Clinical endpoint definitions following percutaneous coronary intervention and their relationship to late mortality: An assessment by attributable risk. In Heart. Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Chew, D., Kangaharan, N., Evans, G., Astley, C., Molloy, D., Vaile, J., et al. (2005). The Morbidity, Mortality and Economic Burden of Renal Impairment in Cardiac Intensive Care. In Internal Medicine Journal. Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Perry, R., Coombes, M., Chew, D., De Pasquale, C., Minson, R., Aylward, P., et al. (2005). QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure. In Journal of the American Society of Echocardiography. Cardiac Society of Australia and New Zealand. Perth, Australia.
  • Perry, R., De Pasquale, C., Chew, D., Brown, L., Hamilton, A., Aylward, P., et al. (2005). Coronary artery wall thickness of the left anterior descending artery using high resolution transthoracic echocardiography - intra and inter operator variability. In European Journal of Echocardiography. Cardiac Society of Australia and New Zealand. Perth, Australia. [Link]
  • Kalahasti, V., Chew, D., Nambi, V., Minor, S., Zuzek, R. and Bhatt, D. (2004). The Influence of Metabolic Syndrome on Outcomes After Percutaneous Coronary Intervention. In Interventional Cardiology. AHA. New Orleans, USA. [Link]
  • Chew, D., Bhatt, D., Berger, P., Henry, T., Mccullough, P., Feit, F., et al. (2003). Bivalirudin Provides Increasing Benefit With Declining Renal Function in Percutaneous Coronary Intervention: A Meta-Analysis of 5,035 Patients Enrolled in Three Randomized Trials. In Journal of the American College of Cardiology. American College of Cardiology 52nd Annual Scientific Session. Chicago, USA. [Link]
  • Feit, F., Bittl, J., Lincoff, A., Chew, D., Kleiman, N., Wallentin, L., et al. (2003). Bivalirudin Reduces Ischemic and Hemorrhagic Complications of Percutaenous Coronary Intervention: Pooled Data From 10 Prospective Studies in 6,134 Patients. In Journal of the American College of Cardiology. ACC. Chicago, USA. [Link]
  • Chan, A., Bhatt, D., Chew, D., Reginelli, J., Vivekananthan, D., Schneider, J., et al. (2003). Marked Survival Benefit Associated With Statin Pretreatment Prior to Percutaneous Coronary Intervention is Dependent Upon the Preprocedural Inflammatory Status. In Journal of the American College of Cardiology. American College of Cardiology 52nd Annual Scientific Session. Chicago, USA. [Link]
  • Reginelli, J., Ghanamah, M., Chew, D., Gurm, H., Casserly, I., Aronow, H., et al. (2003). Impact of the Prediabetic State on Long-Term Outcomes Following Percutaneous Coronary Intervention. In Journal of the American College of Cardiology. ACC. Chicago, USA. [Link]
  • Vivekananthan, D., Bhatt, D., Chew, D., Chan, A., Moliterno, D., Ellis, S., et al. (2003). Clopidogrel Pretreatment Prior to Percutaneous Coronary Intervention Attenuates Periprocedural Rise of C-Reactive Protein. In Journal of the American Journal of Cardiology. ACC. Chicago, USA. [Link]
  • Chan, A., Bhatt, D., Chew, D., Quinn, M., Moliterno, D., Topol, E., et al. (2002). Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention. In Circulation. Scientific Sessions of the American College of Cardiology. Atlanta, Georgia, USA.
  • Lincoff, A., Bittl, J., Kleiman, N., Kereiakes, D., Harrington, R., Sarembock, I., et al. (2002). The REPLACE 1 Trial: A Pilot Study of Bivalirudin Versus Heparin During Percutaneous Coronary Intervention With Stenting and GP IIb/IIIa Blockade. In Journal of the American College of Cardiology. Scientific Sessions of the American College of Cardiology. Atlanta, Georgia, USA. Mar 2002.
  • Moliterno, D., Lange, R., Hamm, C., Meier, B., Di Battiste, P., Lakis, N., et al. (2002). Prolongation of Activated Clotting Time (ACT) With Tirofiban Versus Abciximab and Its Association to Outcome: Results From TARGET. In Journal of the American College of Cardiology. Scientific Sessions of the American College of Cardiology. Atlanta, Georgia, USA. Mar 2002.
Journal articles
  • Chew, D. (2012). National heart foundation response to letter, "ambiguous cardiac troponin recommendations" Heart, Lung and Circulation, 21(3) pp. 198-198.
  • Sabatine, M.S., Cannon, C.P., Gibson, C.M., López-Sendón, J.L., Montalescot, G., Theroux, P., et al. (2005). Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New England Journal of Medicine, 352(12) pp. 1179-1189. [Link]
  • Chew, D.P. (2005). Cost-effectiveness of drug-eluting stents: if only all things were equal. Medical Journal of Australia, 182(8) pp. 376-377.
  • Astley, C., Molloy, D.A., Kangarahan, N., Aylward, P.E., Vaile, J. and Chew, D.P. (2005). Incremental Cost of Invasive Management In the Australian Setting. Heart, Lung and Circulation, 14 pp. 211-211.
  • Chiu, J., Bhatt, D.L., Chew, D.P., Whitlow, P.L., Lincoff, A.M., Ellis, S.G., et al. (2004). Impact of female sex on outcome after percutaneous coronary intervention. American Heart Journal, 148(6) pp. 998-1002. [Link]
  • Chan, A., Bhatt, D., Chew, D., Quinn, M., Moliterno, D., Topol, E., et al. (2001). Stunning mortality benefit of HMG-CoA reductase inhibitors beginning early after percutaneous coronary intervention - results from 6,412 patients. Canadian Journal of Cardiology, 17 pp. 177C-177C.
  • Bhatt, D., Mukherjee, D., Roffi, M., Kapadia, S., Ziada, K., Chew, D., et al. (2001). Is Simultaneous Bilateral Carotid Artery Stenting Safe? Journal of The American College of Cardiology, 37(2)
  • Bhatt, D., Kapadia, S., Chew, D., Mukherjee, D., Ziada, K., Topol, E., et al. (2001). Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. European Heart Journal, 322 pp. 634-634. [Link]
  • Bhatt, D., Chew, D., Robbins, M., Roffi, M., Cho, L., Yadav, J., et al. (2001). Elevated Baseline CRP Levels Predict Death or MI in Diabetic Patients Undergoing Percutaneous Coronary Intervention. Journal of The American College of Cardiology, 37(2)
  • Bhatt, D., Chew, D., Hirsch, A., Ringleb, P., Hacke, W. and Topol, E. (2001). Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation, 104 pp. e76.
  • Chan, A., Chew, D., Bhatt, D., Moliterno, D., Topol, E. and Ellis, S. (2001). Sustained mortality benefit for cardiogenic shock complicating acute MI - Experience from an 8-year registry. Canadian Journal of Cardiology, 17 pp. 213C-213C.
  • Roffi, M., Mukherjee, D., Bhatt, D., Chew, D., Ziada, K., Prosper, D., et al. (2001). Percutaneous coronary interventions of coronary bypass grafts have doubled major adverse events. Journal of The American College of Cardiology, 37(2)
  • Chan, A., Quinn, M., Bhatt, D., Chew, D., Topol, E. and Ellis, S. (2001). Striking mortality benefit of b-blocker within the first year after elective PCI - Results from 6,006 patients. Canadian Journal of Cardiology, 17 pp. 177C-177C.
  • Chew, D., Robbins, M., Bhatt, D., Mukherjee, D., Roffi, M., Topol, E., et al. (2001). CRP provides prognostic value in addition to ACC/AHA lesion score following PCI. Journal of The American College of Cardiology, 37(2) [Link]
  • Cho, L., Ellis, S., Chew, D., Topol, E. and Penn, M. (2001). Patient Rather Than Lesion Specific Predisposition for Restenosis. Journal of The American College of Cardiology, 37(2) [Link]
  • Jeremias, A., Albirini, A., Ziada, K., Chew, D., Roffi, M., Schoenhagen, P., et al. (2001). Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention is a Predictor of Long-Term Mortality in Patients With Renal Dysfunction. Journal of The American College of Cardiology, 37(2)
  • Jeremias, A., Bhatt, D., Chew, D., Ziada, K., Albirini, A., Brener, S., et al. (2001). Glycoprotein IIb-IIIa Inhibition With Abciximab During Percutaneous Coronary Intervention In Patients With Chronic Renal Insufficiency. American Journal of Cardiology, 88
  • Robbins, M., Chew, D., Bhatt, D., Albirini, A., Cho, L., Schneider, J., et al. (2001). Striking Prognostic Significance of elevated CRP in Renal Impairment patients undergoing PCI. Journal of The American College of Cardiology, 37(2) [Link]
  • Roffi, M., Chan, A., Chew, D., Robbins, M., Mukherjee, D., Bhatt, D., et al. (2001). Stents and glycoprotein IIb/IIIa inhibitors do not improve 30-day outcome in bypass graft percutaneous interventions: a retrospective registry-based analysis. Journal of The American College of Cardiology, 37(2) [Link]
  • Roffi, M., Chew, D., Mukherjee, D., Bhatt, D., Robbins, M. and Topol, E. (2001). Glycoprotein IIb/IIIa inhibitors in the medical management of unstable ischemic syndromes without persistent ST-segment elevation: a meta-analysis of the randomized trials. Journal of The American College of Cardiology, 37(2)
  • Chew, D. and Ellis, S. (2000). Cardiogenic Shock: an Editorial. Evidence-based Cardiovascular Medicine,
  • Chew, D. and Topol, E. (2000). Glycoprotein IIb/IIIa Inhibition and Post-operative Acute Myocardial Infarction: A case report. Journal of Invasive Cardiology,
Conference publications
  • Alasady, M., Abhayaratna, W., Lim, H., Leong, D., Roberts-Thomson, K., Chew, D., et al. (2010). Atrial ischemia is an important determinant of atrial fibrillation after myocardial infarction. Cardiac Society of Australia and New Zealand. Adelaide, Australia.
  • Alasady, M., Chew, D., Barlow, D., Lim, H., Leong, D., Brooks, A., et al. (2010). Atrial fibrillation post-myocardial infarction is associated with ventricular fibrillation and poor long term outcomes. Cardiac Society of Australia and New Zealand. Adelaide, Australia.
  • Mattschoss, S., Horsfall, M., Astley, C., Vaile, J., Joseph, M. and Chew, D. (2009). Determining the precipitants of myocardial infarction, a case-crossover study. ESC. Barcelona, Spain.
  • Alasady, M., Abhayaratna, W., Brooks, A., MacKenzie, L., Worthley, M., Chew, D., et al. (2009). Atrial ischemia predicts risk of atrial fibrillation in acute myocardial infarction. Cardiac Society of Australia and New Zealand. Sydney, Australia.
  • Chew, D.P., Amerena, J., Coverdale, S., Rankin, J., Astley, C. and Brieger, D. (2007). Management and outcomes for acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit (ACACIA) In Heart, Lung and Circulation. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S59-S60. [doi:10.1016/j.hlc.2007.06.153]
  • Coverdale, S., Brieger, D., Amerena, J., Rankin, J., Astley, C. and Chew, D.P. (2007). Distance and invasive services for acute coronary syndromes in Australia. In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S120-S121. [doi:10.1016/j.hlc.2007.06.306]
  • Erickson, M., Rankin, J., Amerena, J., Brieger, D., Coverdale, S., Huynh, L., et al. (2007). Reperfusion therapy in STEMI: ACACIA registry contemporary Australian data. In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S124-S124. [doi:10.1016/j.hlc.2007.06.314]
  • Hung, J., Chew, D.P., Amerena, J., Coverdale, S., Rankin, J., Astley, C., et al. (2007). Implications of diabetes in patients with acute coronary syndromes (ACS): Experience from the ACACIA (Australian acute coronary syndromes prospective audit) registry. In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S125-S125. [doi:10.1016/j.hlc.2007.06.317]
  • Huynh, L., Astley, C., Amerena, J., Brieger, D., Coverdale, S., Rankin, J., et al. (2007). The relative and absolute impact of therapies for acute coronary syndrome (ACS) on 6 month events: a nested case-control analysis of the Australian Collaborative Acute Coronary Syndromes Prospective Audit (ACACIA) In Heart, Lung and Circulation. Cardiac Society of Australia and New Zealand Annual Scientific Meeting, pp. S126-S127. [doi:10.1016/j.hlc.2007.06.320]
  • Huynh, L., Chew, D., Sladek, R., Phillips, P., Brieger, D. and Zeitz, C. (2007). Perception is far from reality: unrecognised treatment gags in acute coronary syndromes. Cardiac Society of Australia and New Zealand. Christchurch, NZ.
  • Huynh, L.T., Chew, D.P., Sladek, R.M., Phillips, P.A., Brieger, D.B. and Zeitz, C.J. (2007). Perception is Far from Reality: Unrecognised Treatment Gaps in Acute Coronary Syndrome. In Heart, Lung and Circulation. Cardiac Society of Australia and New Zealand Annual Scientific Meeting, pp. S126-S126. [10.1016/j.hlc.2007.06.319]
  • Joynt, K., Huynh, L., Amerena, J., Brieger, D., Coverdale, S., Rankin, J., et al. (2007). The association between admission risk status and use of performance measure therapies in patients presenting with ST-elevation and non-ST-elevation myocardial infarction. Cardiac Society of Australia and New Zealand. Christchurch, NZ.
  • Medi, C., Brieger, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C., et al. (2007). An invasive management strategy is associated with improved outcomes in high risk acute coronary syndromes in patients with chronic kidney disease (CDK) In R Jeremy, R Rosenfeldt, et al., ed. Heart, Lung and Circulation Supplement: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Chatswood, NSW: Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, New Zealand. Aug 2007, pp. S128-S129. [doi:10.1016/j.hlc.2007.06.325]
  • Morrison, H., Molloy, D., Astley, C., Chang, E., Hii, I. and Chew, D. (2007). How well do physicians document in hospital outcomes of acute coronary syndrome (ACS)? Cardiac Society of Australia and New Zealand. Christchurch, NZ.
  • Penhall, A., Perry, R., De Pasquale, C., Chew, D. and Joseph, M. (2007). Regional values of two dimensional strain in the normal population using speckle tracking. Cardiac Society of Australia and New Zealand. Christchurch, NZ.
  • Reid, C., Nelson, M., Connor, G., Chew, D.P., Shiel, L. and De Looze, F. (2007). Risk factor control in patients at high-risk of atherothrombosis in Australian general practice - local results from the Reach Registry. In Heart, Lung and Circulation. Supplement 2 ed. Cardiac Society of Australia and New Zealand. Christchurch, NZ. [10.1016/j.hlc.2007.06.485]
  • Tideman, P., Aylward, P., Chew, D., De Pasquale, C., Vaile, J., Joseph, M., et al. (2007). Cardiac clinical network, improving cardiac care in rural centres. Cardiac Society of Australia and New Zealand. Christchurch, NZ.
  • Amerena, J., Brieger, D., Coverdale, S., Rankin, J., Huynh, L., Astley, C., et al. (2007). The ACACIA registry - Frequency of in-hospital complications and their association with 6-month mortality after Acute Coronary Syndromes (ACS) In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S122-S123. [doi:10.1016/j.hlc.2007.06.311]
  • Astley, C., Amerena, J., Brieger, D., Coverdale, S., Rankin, J., Huynh, L., et al. (2007). Identifying the factors contributing to poorer outcome in women in the Acute Coronary Syndromes Prospective Audit (ACACIA) In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S119-S119. [doi:10.1016/j.hlc.2007.06.302]
  • Worthley, M.I., Juergens, C., Amerena, J., Coverdale, S., Rankin, J., Worthley, S.G., et al. (2007). A 6-month follow-up comparison of drug eluting with bare metal stents in the treatment of acute coronary syndromes: on behalf of Australian acute coronary syndromes prospectIve audit (ACACIA) study investigators. In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier Ltd. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting 2007. Christchurch, NZ. Aug 2007, pp. S174-S174. [doi:10.1016/j.hlc.2007.06.433]
  • Chew, D.P., Amerena, J., Brieger, D., Rankin, J., Coverdale, S., Astley, C., et al. (2007). Low rates of adverse outcome among acute coronary syndromes patients: observations from the Australian acute coronary syndromes prospective audit (ACACIA) In Journal of the American College of Cardiology: Abstracts of Original Contributions: Presented at the American College of Cardiology 56th Annual Scientific Session. American College of Cardiology 56th Annual Scientific Sesstion. New Orleans, Louisiana. Mar 2007, pp. 199A-199A. [doi:10.1016/j.jacc.2007.01.039]
  • Brieger, D., Amerena, J., Coverdale, S., Rankin, J., Astley, C. and Chew, D.P. (2007). Logistics of ACS management in rural versus metropolitan hospitals. In Heart, Lung and Circulation: Abstracts for the Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Elsevier. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research, Australasian Section, Annual Scientific Meeting. Christchurch, NZ. Aug 2007, pp. S121-S121. [doi:10.1016/j.hlc.2007.06.307]
  • Greenwell, T., Teo, K., Chew, D., Hammett, C., Piantadosi, C., Carbone, A., et al. (2006). Early atherosclerotic disease in the carotid and coronary territories in at-risk individuals. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Dundon, B., Psaltis, P., Worthley, M., Shakib, S., Mahar, L., Chew, D., et al. (2006). Outcomes of intubated patients post cardiac arrest undergoing primary PCI in STEMI: The Royal Adelaide Hospital experience. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Dalton, A., Chew, D., Sundaraja, V. and Osborne, R. (2006). Drug eluting stents; are they only cost-effective in clinical trials? Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Chew, D., Dedrick, R., Anderson, F., Avezum, A., Eagle, K., Gulba, D., et al. (2006). Impact of clinical guideline adherence on 6-month survival: case control analysis from the GRACE registry. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Chew, D., Amerena, J., Brieger, D., Coverdale, S., Rankin, J. and Hughes, K. (2006). Current management of acute coronary syndromes in Australia: The ACACIA registry. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Bridgman, J., Large, A., Molaee, P., Lehman, S. and Chew, D. (2006). Which guideline strategies are associated with the greatest effect in 6-month mortality from acute coronary syndromes? Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Astley, C., Molloy, D.A., Vaile, J., Aylward, P.E. and Chew, D.P. (2006). The relative contribution of risk stratification components to 6-month mortality in ACS. In Heart, Lung and Circulation. CSANZ Annual Scientific Meeting 2006. Canberra, ACT. Aug 2006, pp. S86-S86. [doi:10.1016/j.hlc.2006.05.003]
  • Astley, C., Molloy, D., Vaile, J., Aylward, P. and Chew, D. (2006). The relative contribution of risk stratification components to 6-month mortality in ACS. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Huynh, L., Astley, C., De Pasquale, C., Vaile, J., Aylward, P. and Chew, D. (2006). Patient factors and the usage of acute coronary syndrome clinical guidelines. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Yong, G., Rankin, J., Ferguson, L., Thom, J., French, J., Brieger, D., et al. (2006). Platelet responsiveness to Aspirin and Clopidogrel and troponin increment after intervention in acute coronary artery lesions. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Tideman, P., Aylward, P., Chew, D., De Pasquale, C., Vaile, J., Joseph, M., et al. (2006). Integrated cardiac assessment regional network. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Schrale, R., Siebert, W., Girardi, J., Joseph, M., Vaile, J., McRitchie, R., et al. (2006). Renal injury prevention in contrast induced nephropathy with acetylcysteine (RIPCINA) trial - a randomised controlled trial of n-acetylcysteine with short and medium term (30 day) follow up. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Schrale, R., Shinnick, M., Chew, D. and Aylward, P. (2006). A national survey of radiation knowledge and safety in the cardiac catheterisation laboratory. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Perry, R., De Pasquale, C., Chew, D., Brown, L., Aylward, P. and Joseph, M. (2006). Non-invasive detection of coronary artery atherosclerosis: a high resolution transthoracic echocardiography study. Cardiac Society of Australila and New Zealand. Canberra, Australia.
  • Perry, R., De Pasquale, C., Chew, D. and Joseph, M. (2006). Assessment of early diastolic left ventricular function by 2D echocardiographic speckle tracking. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Molaee, P., Lehman, S., Bridgman, C., Astley, C., Tideman, P.A., Aylward, P.E., et al. (2006). The poor man's multi-marker approach to risk stratification in acute coronary syndromes. In Heart, Lung and Circulation. CSANZ Annual Scientific Meeting 2006. Canberra, ACT. Aug 2006, pp. S91-S92. [doi:10.1016/j.hlc.2006.05.003]
  • Molaee, P., Lehman, S., Bridgman, C., Astley, C., Tideman, P., Aylward, P., et al. (2006). The poor man's multi-marker approach to risk stratification in acute coronary syndromes. Cardiac Society of Australia and New Zealand. Canberra, Australia.
  • Molaee, P., Lehman, S., Bridgman, C., Astley, C., De Pasquale, C.G. and Chew, D.P. (2006). Closing the gap: are diabetics still at excess risk with guideline mandated medical therapy in acute coronary syndromes. In Heart, Lung and Circulation. CSANZ Annual Scientific Meeting 2006. Canberra, ACT. Aug 2006, pp. S89-S90. [doi:10.1016/j.hlc.2006.05.003]
  • Molaee, P., Lehman, S., Bridgman, C., Astley, C., De Pasquale, C. and Chew, D. (2006). Closing the gap: are diabetics still at excess risk with guideline mandated medical therapy in acute coronary syndromes. Cardiac Society of Australia and New Zealand. Canberra, Australia.

Professional and community engagement

Expertise for media contact

  • Cardiology
  • Acute Coronary Syndromes


inspiring achievement